Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers
NCT01237353 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2013-07-02
Summary
In this study the investigators will test a nutritional supplement called betaine hydrochloride to see if it can temporarily increase the stomach acid in healthy volunteers who have decreased stomach acid because they take a medicine called rabeprazole.
Conditions
- Pharmacodynamic
Interventions
- DIETARY_SUPPLEMENT
-
betaine hydrochloride
betaine hydrochloride 1500mg po x 1 on day 5
- DRUG
-
Rabeprazole
rabeprazole po daily x 5 days
Sponsors & Collaborators
-
University of California, San Francisco
lead OTHER
Principal Investigators
-
Leslie Benet, PhD · University of California, San Francisco
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 59 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- United States
Study Locations
More Related Trials
-
Obeticholic Acid in Bariatric and Gallstone Disease
NCT01625026 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
NCT05314374 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis
NCT01438411 ·Status: COMPLETED ·Phase: PHASE3
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Impact of Foods on Bile Acids, Metabolites, and Inflammation
NCT05245357 ·Status: UNKNOWN ·Phase: NA
-
Determination of Pre-Absorptive Dissociation of Zinc From a Zinc Amino Acid Complex in Healthy Men
NCT03934346 ·Status: COMPLETED ·Phase: NA
-
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004697 ·Status: COMPLETED ·Phase: NA
-
GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis
NCT01589523 ·Status: COMPLETED ·Phase: PHASE3
-
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
NCT01191177 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Efficacy of Pancrelipase on Postprandial Belching and Bloating.
NCT00266721 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
NCT00004346 ·Status: UNKNOWN ·Phase: PHASE2
-
REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID
NCT05840237 ·Status: COMPLETED ·Phase: NA
-
Total Parenteral Nutrition-Associated Liver Disease
NCT00031135 ·Status: TERMINATED ·Phase: PHASE2
-
Therapeutic Effect of Bifidobacterium Longum in Patients with Acute Pancreatitis: a Randomized, Double-Blind, Placebo-Controlled Trial
NCT06639516 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Obeticholic Acid in Morbidly Obese Patients and Healthy Volunteers
NCT02532335 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
NCT00004441 ·Status: COMPLETED ·Phase: NA
-
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT
NCT03253276 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease
NCT01739517 ·Status: UNKNOWN ·Phase: PHASE2
-
Chromium Picolinate for the Treatment of Metabolic Syndrome
NCT00128154 ·Status: COMPLETED ·Phase: NA
-
ButyraGen™, Short Chain Fatty Acids and Gut Microbiome
NCT05601635 ·Status: COMPLETED ·Phase: NA
-
Bile Acids As Determinants of Postprandial Metabolism
NCT06758453 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
NCT01846806 ·Status: TERMINATED ·Phase: NA
-
Use of Ravicti™ in Patients With MCAD Deficiency With the 985A>G (K304E) Mutation
NCT01881984 ·Status: COMPLETED ·Phase: PHASE1
-
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
NCT04542473 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3